Approval · Notice of Compliance 33818 · 2024
CABTREO: Notice of Compliance 33818
Issued August 14, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33818
- Date
- August 14, 2024
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CABTREO | 02550423 | Marketed |
Medicinal ingredients
- BENZOYL PEROXIDE 3.1 PER
- CLINDAMYCIN PHOSPHATE 1.2 PER
- ADAPALENE 0.15 PER